Post by Actusnews Wire

AMOEBA : Amoéba has received marketing authorization in France for its biofungicide AXPERA: Chassieu (France), 30 June 2026 – 07:30 am - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, announces that it has obtained marketing authorization for its biofungicide AXPERA in France. This first authorisation, granted by ANSES following the evaluation conducted by France in its capacity as rapporteur Member State for European Union, now allows the other concerned Member States concerned to proceed with and finalise their national authorisation procedures in the coming weeks and months, according to each country's specific timelines. This authorization, which is crucial for Amoéba, marks the launch of the commercialization phase for AXPERA in partnership with Koppert, initially in France and then in the other European countries covered by the agreement once approvals have been granted by the relevant national authorities. An authorisation covering a wide range of uses in vineyards and vegetable crops AXPERA is approved by ANSES[1] as a fungicide that acts by inhibiting the germination of fungal spores. The product is now approved for the following uses: Crop Disease Open field and/or protected conditions Grapes (wine and table grapes) Downy mildew Open field Grapes (wine and table grapes) Powdery mildew Open field Cucurbits Downy mildew Open field Cucurbits Powdery mildew Open field and protected conditions Tomatoes Late blight Open field and protected conditions Eggplant Late blight Open field and protected conditions Tomatoes Powdery mildew Protected conditions Eggplant Powdery mildew Protected conditions Basil Downy mildew Open field Lettuce (including baby leafs) Downy mildew Open field Artichokes Downy mildew Open field The product is intended for preventive use; it can be used alone, as part of a treatment program, or in combination with other fungicides approved for use against the specific disease. Very favorable conditions of use AXPERA is approved as a low-risk product and can be used in both conventional and organic agriculture in accordance with applicable regulations. The authorized application conditions of use contribute to the product's appeal to farmers by combining protection, effectiveness, and ease of use. In particular, they result in the shortest re-entry period[2] and pre-harvest interval[3], as well as the shortest safety distances[4] granted by ANSES for a plant protection product. In addition, the active ingredient of AXPERA, the “Lysate of Willaertia magna C2c Maky,” is included on the list of active ingredients exempt from maximum residue limits (MRLs),…